Advanced search
Search:  

1 - 4 of 4 results found for EPB41L3.

  1. EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse...

    http://iris.ucl.ac.uk/iris/publication/1012184/3

  2. UCL scientists discover how to switch cancer 'protector' gene...

    The researchers found that the 'protector gene', known as EPB41L3, is inactivated in 65 per cent of ovarian cancers and reactivating the gene halted tumour growth and triggered large numbers of ... UCL's Dr Simon Gayther, who led the study, said:

    https://www.ucl.ac.uk/news/2010/jul/ucl-scientists-discover-how-switch-cancer-protector-gene

  3. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of...

    We used a functional complementation approach to identify tumor-suppressor genes and putative therapeutic targets for ovarian cancer. Microcell-mediated transfer of chromosome 18 in the ovarian cancer cell line TOV21G induced in vitro and in vivo

    http://iris.ucl.ac.uk/iris/publication/248863/2

  4. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer...

    We analysed the promoter methylation status of five genes, involved in adhesion (EPB41L3, TSLC-1), apoptosis (RASSF1, RASSF2) or angiogenesis (TSP-1), in intraoperative sentinel lymph node (SLN) biopsy samples from patients with breast cancer, that

    http://iris.ucl.ac.uk/iris/publication/1125658/1

  5. Page: 1